213 related articles for article (PubMed ID: 24725950)
1. Antibody neutralization of retargeted measles viruses.
Lech PJ; Pappoe R; Nakamura T; Tobin GJ; Nara PL; Russell SJ
Virology; 2014 Apr; 454-455():237-46. PubMed ID: 24725950
[TBL] [Abstract][Full Text] [Related]
2. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
[TBL] [Abstract][Full Text] [Related]
3. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.
Lech PJ; Tobin GJ; Bushnell R; Gutschenritter E; Pham LD; Nace R; Verhoeyen E; Cosset FL; Muller CP; Russell SJ; Nara PL
PLoS One; 2013; 8(1):e52306. PubMed ID: 23300970
[TBL] [Abstract][Full Text] [Related]
4. Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.
Muñoz-Alía MÁ; Muller CP; Russell SJ
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356529
[TBL] [Abstract][Full Text] [Related]
5. MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
Muñoz-Alía MÁ; Nace RA; Tischer A; Zhang L; Bah ES; Auton M; Russell SJ
PLoS Pathog; 2021 Feb; 17(2):e1009283. PubMed ID: 33534834
[TBL] [Abstract][Full Text] [Related]
6. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced neutralizing antibodies bind to the H protein of a historical measles virus.
Zemella A; Beer K; Ramm F; Wenzel D; Düx A; Merkel K; Calvignac-Spencer S; Stern D; Dorner MB; Dorner BG; Widulin N; Schnalke T; Walter C; Wolbert A; Schmid BG; Mankertz A; Santibanez S
Int J Med Microbiol; 2024 Mar; 314():151607. PubMed ID: 38367508
[TBL] [Abstract][Full Text] [Related]
8. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
[TBL] [Abstract][Full Text] [Related]
9. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
11. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
[TBL] [Abstract][Full Text] [Related]
12. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.
Ziegler D; Fournier P; Berbers GA; Steuer H; Wiesmüller KH; Fleckenstein B; Schneider F; Jung G; King CC; Muller CP
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2479-89. PubMed ID: 8887481
[TBL] [Abstract][Full Text] [Related]
13. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity.
Allen C; Vongpunsawad S; Nakamura T; James CD; Schroeder M; Cattaneo R; Giannini C; Krempski J; Peng KW; Goble JM; Uhm JH; Russell SJ; Galanis E
Cancer Res; 2006 Dec; 66(24):11840-50. PubMed ID: 17178881
[TBL] [Abstract][Full Text] [Related]
14. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
[TBL] [Abstract][Full Text] [Related]
15. Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope.
Finsterbusch T; Wolbert A; Deitemeier I; Meyer K; Mosquera MM; Mankertz A; Santibanez S
J Gen Virol; 2009 Nov; 90(Pt 11):2739-2745. PubMed ID: 19625457
[TBL] [Abstract][Full Text] [Related]
16. The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.
Tahara M; Ohno S; Sakai K; Ito Y; Fukuhara H; Komase K; Brindley MA; Rota PA; Plemper RK; Maenaka K; Takeda M
J Virol; 2013 Mar; 87(6):3583-6. PubMed ID: 23283964
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
19. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
[TBL] [Abstract][Full Text] [Related]
20. Mucosal adenovirus-vectored vaccine for measles.
Lobanova LM; Baig TT; Tikoo SK; Zakhartchouk AN
Vaccine; 2010 Nov; 28(48):7613-9. PubMed ID: 20887832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
